Another record high: 51 Class 1 innovative drugs enter the new national medical insurance drug catalog.

The reporter learned from the National Healthcare Security Administration on November 14 that the 2026 national medical insurance drug catalog and the commercial health insurance innovative drug catalog were released in Suzhou. The new version of the national medical insurance drug catalog adds 107 drugs, including 51 Class 1 new drugs, once again setting a new record high. The newly added varieties cover multiple clinical fields with urgent needs, such as oncology, rare diseases, chronic diseases, and mental illnesses. The adjustment of the commercial health insurance innovative drug catalog was carried out simultaneously, adding 12 drugs, including major innovative drugs such as the world's first CAR-T for solid tumors and China's first gene therapy drug for hemophilia. After the adjustment, the 2026 commercial health insurance innovative drug catalog contains a total of 28 drugs. Following this adjustment, the total number of drugs in the 2026 version of the national medical insurance drug catalog reaches 3,331, including 1,935 Western medicines and 1,396 Chinese patent medicines. The new version of the catalog will be officially implemented on January 1, 2027.